We are live on ! Find out more
HI

Humankind Investments Portfolio holdings

AUM $175M
1-Year Est. Return 14.3%
This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+14.3%
3 Year Est. Return
+46.43%
5 Year Est. Return
+54.92%
10 Year Est. Return
AUM
$395M
AUM Growth
+$118M
Cap. Flow
+$125M
Cap. Flow %
31.74%
Top 10 Hldgs %
64.17%
Holding
156
New
15
Increased
70
Reduced
60
Closed
4

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.95M
2
INTC icon
Intel
INTC
+$282K
3
LEN.B icon
Lennar Class B
LEN.B
+$224K
4
CTLT
CATALENT, INC.
CTLT
+$221K
5
DVA icon
DaVita
DVA
+$204K

Sector Composition

Rank Sector Weight
1 Technology 12.75%
2 Healthcare 12.24%
3 Consumer Staples 5.17%
4 Communication Services 2.96%
5 Materials 2.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADM icon
26
Archer Daniels Midland
ADM
$36.9B
$2.32M 0.59%
45,991
+6,074
+15% +$329K
CTVA icon
27
Corteva
CTVA
$51.3B
$2.18M 0.55%
38,273
+264
+0.7% +$15.6K
CL icon
28
Colgate-Palmolive
CL
$74.4B
$2.05M 0.52%
22,538
+2,768
+14% +$264K
INTC icon
29
Intel
INTC
$513B
$1.95M 0.49%
97,164
-12,488
-11% -$282K
BDX icon
30
Becton Dickinson
BDX
$48.7B
$1.81M 0.46%
7,990
+685
+9% +$158K
WMT icon
31
Walmart Inc
WMT
$890B
$1.7M 0.43%
18,825
-2,013
-10% -$175K
ABT icon
32
Abbott
ABT
$187B
$1.64M 0.42%
14,502
-25
-0.2% -$2.89K
AMGN icon
33
Amgen
AMGN
$222B
$1.56M 0.39%
5,985
+1,009
+20% +$299K
SYK icon
34
Stryker
SYK
$130B
$1.56M 0.39%
4,320
-460
-10% -$170K
CI icon
35
Cigna
CI
$74.6B
$1.46M 0.37%
5,294
+571
+12% +$182K
CF icon
36
CF Industries
CF
$17.3B
$1.45M 0.37%
16,948
-539
-3% -$46.6K
BMY icon
37
Bristol-Myers Squibb
BMY
$132B
$1.42M 0.36%
25,151
-2,297
-8% -$128K
LH icon
38
Labcorp
LH
$25.9B
$1.4M 0.35%
6,095
+115
+2% +$26.4K
GEHC icon
39
GE HealthCare
GEHC
$32.4B
$1.4M 0.35%
17,876
+1,350
+8% +$115K
TMO icon
40
Thermo Fisher Scientific
TMO
$220B
$1.37M 0.35%
2,626
+477
+22% +$262K
VZ icon
41
Verizon
VZ
$196B
$1.32M 0.33%
32,908
+787
+2% +$33.2K
ECL icon
42
Ecolab
ECL
$79.9B
$1.32M 0.33%
5,615
+134
+2% +$33.3K
HCA icon
43
HCA Healthcare
HCA
$89.5B
$1.3M 0.33%
4,317
+573
+15% +$200K
DELL icon
44
Dell
DELL
$293B
$1.29M 0.33%
11,152
-1,454
-12% -$182K
UNH icon
45
UnitedHealth
UNH
$370B
$1.28M 0.32%
2,529
+47
+2% +$26.7K
T icon
46
AT&T
T
$163B
$1.25M 0.32%
54,727
-6,733
-11% -$152K
BG icon
47
Bunge Global
BG
$20.8B
$1.22M 0.31%
15,746
+1,490
+10% +$131K
BAX icon
48
Baxter International
BAX
$14.2B
$1.17M 0.3%
40,157
+6,259
+18% +$211K
BSX icon
49
Boston Scientific
BSX
$71.5B
$1.13M 0.29%
12,676
-654
-5% -$57.6K
GILD icon
50
Gilead Sciences
GILD
$165B
$1.13M 0.29%
12,257
-1,891
-13% -$170K

Similar funds

Humankind Investments's Q4 2024 Portfolio in Review

As of Q4 2024, Humankind Investments held 156 positions worth $395M, up 43% from $277M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Humankind Investments deployed $125M of net new capital in Q4 2024, opening 15 new positions and adding to 70 existing holdings. Its largest new stake was Invesco QQQ Trust: 86,575 shares worth $44.3M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.95M trimmed.

  • Humankind Investments's largest Q4 2024 buy was Invesco QQQ Trust: 86,575 shares worth $44.3M.
  • Humankind Investments added most to Humankind US Stock ETF in Q4 2024, an estimated $858K increase.
  • Humankind Investments's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $1.95M.
  • Humankind Investments fully exited Lennar Class B in Q4 2024, selling an estimated $224K.
  • Humankind Investments's ten largest holdings make up 64% of its $395M portfolio in Q4 2024.
  • Humankind Investments opened 15 new positions and closed 4 in Q4 2024.
  • Humankind Investments's portfolio value rose 43% quarter-over-quarter to $395M.

Based on Humankind Investments's 13F filing for Q4 2024, filed 14 Feb 2025.